Cordyceps Sunshine Biotech Holdings Co., Ltd. specializes in the cultivating and sale of cordyceps. The company is headquartered in Taipei City, Taipei and currently employs 15 full-time employees. The company went IPO on 2023-10-09. The primary product is Cordyceps, Ophiocordyceps Sinensis, a valuable Chinese medicinal material with a long history of application in China. The firm produces two kinds of Cordyceps, including dry Cordyceps and fresh Cordyceps. Dry cordyceps has a long shelf life and is convenient to store and carry, fresh Cordyceps has a short shelf life and is inconvenient to store and carry. The products are cultivated in its breeding center. The firm commissioned third party quality testing institution to perform quality testing for products to ensure quality control.

Industry: Medicinal Chemicals & Botanical Products